Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Invitrogen, David Onions, Ph.D., Chief Medical Officer
10-24-2005
SHARING OPTIONS:

CARLSBAD, Calif.—Invitrogen Corp. recently promoted David Onions, Ph.D., to the newly created position of chief medical officer. In this new role, Dr. Onions will be responsible for guiding the company's scientific efforts as it moves into areas more closely associated with medical research and closer to patients, such as stem cell technologies, diagnostics support and other clinical studies. Additionally, the position will focus on developing important new corporate relationships and working successfully with regulatory agencies.
 
Dr. Onions joined Invitrogen in 2003. He was a founder and Director of Q-One Biotech, Ltd., which was acquired by Invitrogen through its purchase of BioReliance. Most recently, he served as chief scientific officer for BioReliance.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.